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Summary and Implications 
Ovomucin was hydrolyzed using enzymes or by heating 
under alkaline conditions (pH 12.0), and the functional, 
structural and compositional characteristics of the peptides 
in the hydrolysates were determined. Among the treatments, 
heating at 100 oC for 15 minutes under alkaline conditions 
(OM) produced peptides with the highest iron-binding and 
antioxidant capacities. Ovomucin hydrolyzed with papain 
(OMPa) or alcalase (OMAl) produced peptides with high 
ACE-inhibitory activity. The mass spectrometry analysis 
indicated that most of the peptides from OMPa were < 2 
kDa, but peptides from OMTr and OM were > 2 kDa. 
OMAl hydrolyzed ovomucin almost completely and no 
peptides within 700-5,000 Da were found in the hydrolasate. 
The results indicated that the number and size of peptides 
were closely related to the functionality of the hydrolysates. 
Considering the time, cost and activities of the hydrolysates, 
OM was the best treatment for hydrolyzing ovomucin to 
produce functional peptides. 
 
Introduction 
Ovomucin is a sulfated glycoprotein with molecular 
weight ranges from 150 kDa to 23,000 kDa and is 
responsible for the gel-like structure of thick in egg 
albumin. Enzymatic hydrolysis is one of the methods to 
improve functional properties of ovomucin. Hydrolysis of 
ovomucin with Neutraese, Flavourzyme, Alcalase, or 
Pronase E produced peptides with strong foaming 
capacities, but had low foam stabilities. The pronase 
hydrolysis of ovomucin produced an ovomucin 
glycopeptide that has E. coli O157:H7-specific binding 
sites, and suggested that this peptide could be used as an 
antimicrobial agent against E. coli O157:H7 and to be a 
novel probe for the detection of E. coli O157:H7 in the 
foods. The hydrolysates of ovomucin had strong antioxidant 
effects. The objectives of this study were 1) to develop a 
simple and easy way of hydrolyzing ovomucin, 2) to 
determine the functional characteristics (antioxidant, metal 
chelating, and ACE-inhibitory) of the peptides in the 
hydrolysates, and 3) to elucidate the compositional and 
structural characteristic of the peptides in the hydrolysates. 
  
 
 
Materials and Methods 
The lyophilized ovomucin was dissolved in distilled 
water at 20 mg/ml concentration and used in this study. The 
pH of the ovomucin solution was adjusted for the optimal 
conditions for each enzyme (pepsin pH 2.5, trypsin pH 7.8, 
papain pH 6.5 and alcalase pH 6.5) under room temperature 
for optimal enzyme hydrolysis. Pepsin, trypsin, or papain 
were dissolved in distilled water (20 mg enzyme/ml) before 
use, but Alcalase® 2.4L was in aqueous form and used as is. 
Each enzyme was added to ovomucin solution (enzyme: 
substrate ratio at 1:100) and incubated at 37 oC for 0, 3, 6, 9, 
12 and 24 hr. At the end of incubation, the samples were 
heated at 100 oC for 15 min to inactivate the enzyme. Also, 
hydrolysis of ovomucin by heating (100 oC for 15 min) 
under alkaline conditions (pH 12.0) was tested. SDS-PAGE 
gels (15%) were used to analyze the peptides derived from 
ovomucin. Antioxidant, ACE-inhibitory, Fe-chelating and 
Cu-chelating activity of the hydrolyzed ovomucin were also 
measured. The peptides in the hydrolysates were determined 
using a LC-nano ESI-MS/MS system. Data were analyzed 
with MINITAB16.0 (Minitab Ltd., UK) statistical software. 
One way ANOVA was used: Least significance difference 
(LSD) tests were performed for the significant differences 
(P < 0.05) among means. All trials were replicated three 
times.  
 
Results and Discussion 
The lyophilized ovomucin was very difficult to dissolve 
in water under neutral or acidic pH conditions. However, the 
ovomucin was easily solubilized at pH > 12.0, and the 
majority was hydrolyzed by heating at 100 oC for 15 min 
(Figure 1). Increasing heating time longer than 15 min did 
not increase hydrolysis but turned the color of ovomucin 
into brown probably due to caramelization reaction of 
carbohydrate units in the protein. Incubating ovomucin with 
1% pepsin at 37 oC for 24 h changed the ovomucin solution 
into a gel-like conditions even though the hydrolysis 
proceeded well (Figure 2). Treating ovomucin with trypsin 
produced small peptides (Figure 2), but the hydrolysis was 
not as complete as that of alcalase treatment (Figure 3). 
Treating ovomucin with 1% papain for 3 h also hydrolyzed 
ovomucin well (Figure 3), even though SDS-PAGE does 
not show any difference between 0 h and 3 h treatments. 
One difference between the 0 h and 3 h hydrolysis using 1% 
papain was that 0 h hydrolysis of ovomucin with papain 
produced precipitated proteins after heat inactivation of the 
enzyme. Therefore, incubating for 3 h at 37 oC was selected 
as the optimum time and temperature combination for 
papain. According to the results, four treatments were 
selected as the best treatments for hydrolyzing ovomucin. 
The four selected treatments include heating ovomucin 
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solution at pH 12.0 for 15 minutes at 100 oC (OM), 
hydrolyzing ovomucin with 1% trypsin at 37 oC for 3 h 
(OMTr), hydrolyzing ovomucin with 1% alcalase at 37 oC 
for 3 h (OMAl), and hydrolyzing ovomucin with 1% papain 
at 37 oC for 3 h (OMPa). These four treatments were used to 
analyze their metal-chelating, antioxidant and ACE-
inhibitory activities.  
Ovomucin hydrolyzed by heating at 100 oC for 15 
minutes under pH 12.0 (OM) had a strong antioxidant 
activity (Figure 4A). The TBARS value of oil emulsion 
added with the hydrolysates was only 1/3 of the control. 
However, hydrolysates from other treatments increased the 
TBARS value of oil emulsion, indicating that they have 
strong prooxidant effects. The antioxidant activity of 
peptides from ovomucoid varied greatly depending upon the 
enzymes or conditions used to hydrolyze it. Hydrolysates 
from OMPa and OMAl treatments showed the highest ACE-
inhibitory activity (> 70%) followed by OMTr with 65% 
inhibition (Figure 4B). However, the hydrolysates from OM 
treatment did not show a strong ACE-inhibitory activity. 
Therefore, ovomucin hydrolyzed with 1% alcalase (OMAl) 
and ovomucin hydrolyzed with 1% papain (OMPa) can be 
considered as good treatments to produce peptides with 
ACE-inhibitory activity. The results indicated that OMPa, 
OMAl, and OMTr treatments can be used to produce 
functional peptides with ACE-inhibitory activities.  Figure 
5A indicated that ovomucin hydrolyzed by heating at 100 oC 
for 15 minutes under pH 12.0 (OM) showed a high iron-
chelating activity (P < 0.05). OMTr showed some iron-
chelating activity, but other two treatments (OMAl and 
OMPa) showed very low iron-chelating activities. It was 
observed that ovomucin had a capability of controlling 
bacteria such as Escherichia coli, Bacillus dysentericus, and 
Vibrio bacterium. With a high iron-chelating activity, 
microbial growth can be reduced. Therefore, these peptides 
can be used as antimicrobial agents for foods. Because the 
peptides produced from ovomucin through alkaline 
hydrolysis followed by heat treatment (OM) showed a high 
iron-chelating activity, the hydrolysates from OM treatment 
can be helpful in preventing oxidative changes and 
microbial growth in foods. The Cu2+-chelating activity of the 
peptides from ovomucin was totally different from that of 
the iron-chelating activity. It was observed that the levels of 
Cu2+ ions in samples with the hydrolyzed products were 
higher than that of the blank, indicating that cupper ions 
were not chelated by the peptides from OMTr, OMAl and 
OMPa treatments (Figure 5B). Therefore, hydrolysates from 
OMTr, OMAl and OMPa are not suitable as antioxidant or 
metal chelating agents.   
The LC-nano ESI-MS/MS potentially identified 642 
peptides with the molecular weight range of 700-5,000 Da 
from the OMTr treatment, 182 from the OMPe hydrolysate, 
and 149 from the OM. The majority (173 out of 182) of the 
peptides from OMPa was smaller than 2 kDa, but more than 
half of the peptides produced from OMTr (371 out of 642 
peptides) and OM (88 out of 149 peptides) was greater than 
2 kDa. No detectable peptides from ovomucin were found in 
the OMAl hydrolasate. This indicated that treating 
ovomucin with 1% alcalase for > 3 hr hydrolyzed ovomucin 
almost completely to produce amino acid monomers, and 
peptides with MW < 700 Da (Figure 3 and Table 1). The 
high ACE-inhibitory activity of OMAl treatment can be 
related to the small peptide sizes, but it cannot be confirmed 
in this study. OMPa treatment produced smaller peptides 
than OM and OMTr treatments (Table 1).  
The ACE-inhibitory, antioxidant and iron-chelating 
activities of the enzyme hydrolysates (Figures 4-5) indicated 
that the number (also amount) and size of peptides were 
closely related to the functionality of the hydrolysates: as 
the protein became hydrolyzed to smaller peptides, the 
antioxidant and Fe-chelating activities decreased while the 
ACE-inhibitory activity increased. At this point, however, 
no information about the amount of each peptide present in 
the hydrolysates is available.  It is highly unlikely that 
certain functional characteristics of enzyme hydrolysates are 
derived only by one or two specific peptides (out of 
hundreds of peptides), unless their amounts are very high. 
Therefore, finding enzyme treatments that produce group of 
peptides with specific functional characteristics is the first 
step. Production of peptides that share similar functions 
from a protein and using the whole hydrolysate as a food 
ingredient or nutraceutical agents would be more reasonable 
and economical than identifying specific peptides and 
separating them from a hydrolysate before use. 
 
Conclusion 
The functions of hydrolysates can vary significantly 
depending upon the hydrolysis conditions and methods. 
Hydrolysate of OM treatment is suitable for metal-chelating 
and antimicrobial agents, while those of OMPa, OMAl and 
OMTr can be used for ACE-inhibitory agents. Production of 
these peptides is simple and can be easily used in the 
industrial level. Considering the time, cost and activities of 
the hydrolysates, OM treatment was the best for hydrolyzing 
ovomucin (P < 0.05) to produce functional peptides.
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Figure 1: SDS-PAGE of ovomucin hydrolyzed with heat treatment at different temperatures for 15 min at pH 12.0. Lane 1 = 
Marker, Lane 2 = ovomucin (1 mg/ml), Lane 3 = ovomucin at 60 oC for 15 min, Lane 4 = ovomucin at 70 oC for 15 min, Lane 
5 = ovomucin at 80 oC for 15 min, Lane 6 = ovomucin at 90 oC for 15 min, Lane 7 = ovomucin at 100 oC for 15 min. 
 
 
 
 
 
 
Figure 2: SDS-PAGE of ovomucin hydrolyzed with 
pepsin and trypsin. Lane 1 = Marker, Lane 2 = ovomucin 
(1 mg/ml), Lanes 3-8 = ovomucin hydrolyzed with pepsin 
at 37 oC for 0, 3, 6, 9, 12 and 24 h, Lanes 9-14 = 
ovomucin hydrolyzed with trypsin at 37 oC for 0, 3, 6, 9, 
12 and 24 h.  
 
 
 
Figure 3: SDS-PAGE of ovomucin hydrolyzed with 
alcalase and papain. Lane 1 = Marker, Lane 2 = ovomucin 
(1 mg/ml), Lanes 3-8 = ovomucin hydrolyzed with 
alcalase at 37 oC for 0, 3, 6, 9, 12 and 24 h , Lanes 9-14 = 
ovomucin hydrolyzed with papain at 37 oC for 0, 3, 6, 9, 
12 and 24 h. 
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Figure 4. A: TBARS value of oil emulsion (mg MDA/L) in the presence of the hydrolysates from ovomucin, and B: ACE-
inhibitory activity (%) of the hydrolysates from ovomucin (OM = ovomucin hydrolyzed with heating at 100 oC for 15 min at 
pH 12.0, OMT = ovomucin dissolved at pH 12.0 and hydrolyzed with 1% trypsin, OMPa = ovomucin dissolved at pH 12.0 and 
hydrolyzed with 1% papain, OMAl = ovomucin dissolved at pH 12.0 and hydrolyzed with 1% alcalase). a-cValues are mean 
with standard error. Values with different letters are significantly different (P < 0.05). 
 
 
 
Figure 5: Graphical expression of Fe2+- and Cu2+-chelating activity of the hydrolysates from ovomucin (OM = ovomucin 
hydrolyzed with heating at 100 oC for 15 min at pH 12.0, OMT = ovomucin dissolved at pH 12.0 and hydrolyzed with 1% 
trypsin, OMPa = ovomucin dissolved at pH 12.0 and hydrolyzed with 1% papain, OMAl = ovomucin dissolved at pH 12.0 and 
hydrolyzed with 1% alcalase). a-cValues are mean with standard error. Values with different letters are significantly different 
(P < 0.05). 
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Table 1. Effects of enzyme treatments on the sizes and number of peptides produced from ovalbumin1   
        
                 Enzyme treatments    
MW of peptides (Da) OM OMAl OMPa OMT  
700-1,000 4 0 7 61    
1,000-1,500 24 0 93 214   
1,500-2,000 33 0 64 184  
2,000-3,000 33 0 9 184  
3,000-5,000 55 0 0 100  
Total (ProtScores) 149 (0.43) 0  207 (5.82) 743 (34.42)  
1Peptides are identified using a LC-nano ESI-MS/MS. Peptides with ProtScores > 2.0, > 1.3, and > 0.47 have > 99%, > 95%, 
and > 66% probability, respectively. 
Treatments: OM = ovomucin hydrolyzed with heating at 100 oC for 15 min at pH 12.0, OMT = Ovomucin dissolved at pH 12.0 
and hydrolyzed with 1% trypsin, OMPa = Ovomucin dissolved at pH 12.0 and hydrolyzed with 1% papain, OMAl = Ovomucin 
dissolved at pH 12.0 and hydrolyzed with 1% alcalase. 
 
 
